Fintel reports that on December 8, 2025, Oppenheimer upgraded their outlook for Inspire Medical Systems (NYSE:INSP) from Perform to Outperform.
Analyst Price Forecast Suggests 6.36% Downside
As of December 6, 2025, the average one-year price target for Inspire Medical Systems is $128.11/share. The forecasts range from a low of $81.81 to a high of $189.00. The average price target represents a decrease of 6.36% from its latest reported closing price of $136.81 / share.
See our leaderboard of companies with the largest price target upside.
The projected annual revenue for Inspire Medical Systems is 794MM, a decrease of 9.99%. The projected annual non-GAAP EPS is -1.59.
What is the Fund Sentiment?
There are 731 funds or institutions reporting positions in Inspire Medical Systems. This is an decrease of 89 owner(s) or 10.85% in the last quarter. Average portfolio weight of all funds dedicated to INSP is 0.21%, an increase of 16.62%. Total shares owned by institutions decreased in the last three months by 8.33% to 39,634K shares. 
The put/call ratio of INSP is 1.39, indicating a bearish outlook.
What are Other Shareholders Doing?
IJR - iShares Core S&P Small-Cap ETF holds 1,757K shares representing 6.05% ownership of the company. In its prior filing, the firm reported owning 1,834K shares , representing a decrease of 4.38%. The firm decreased its portfolio allocation in INSP by 22.61% over the last quarter.
Citadel Advisors holds 1,748K shares representing 6.02% ownership of the company. In its prior filing, the firm reported owning 9K shares , representing an increase of 99.50%. The firm increased its portfolio allocation in INSP by 10,000.16% over the last quarter.
William Blair Investment Management holds 1,298K shares representing 4.47% ownership of the company. In its prior filing, the firm reported owning 769K shares , representing an increase of 40.72%. The firm decreased its portfolio allocation in INSP by 6.02% over the last quarter.
Baillie Gifford holds 1,084K shares representing 3.73% ownership of the company. In its prior filing, the firm reported owning 1,114K shares , representing a decrease of 2.72%. The firm decreased its portfolio allocation in INSP by 80.73% over the last quarter.
Deerfield Management Company, L.p. holds 1,048K shares representing 3.61% ownership of the company. In its prior filing, the firm reported owning 140K shares , representing an increase of 86.64%. The firm increased its portfolio allocation in INSP by 259.90% over the last quarter.
Fintel is one of the most comprehensive investing research platforms available to individual investors, traders, financial advisors, and small hedge funds.
Our data covers the world, and includes fundamentals, analyst reports, ownership data and fund sentiment, options sentiment, insider trading, options flow, unusual options trades, and much more. Additionally, our exclusive stock picks are powered by advanced, backtested quantitative models for improved profits.
This story originally appeared on Fintel.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
